BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 9177410)

  • 1. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process.
    Mimouni NEH; Paiva I; Barbotin AL; Timzoura FE; Plassard D; Le Gras S; Ternier G; Pigny P; Catteau-Jonard S; Simon V; Prevot V; Boutillier AL; Giacobini P
    Cell Metab; 2021 Mar; 33(3):513-530.e8. PubMed ID: 33539777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of PCOS: A systematic bioinformatics approach to unveil the proteins responsible for PCOS.
    Panda PK; Rane R; Ravichandran R; Singh S; Panchal H
    Genom Data; 2016 Jun; 8():52-60. PubMed ID: 27114910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.
    Hauzman EE; Fancsovits P; Murber A; Rabe T; Strowitzki T; Papp Z; Urbancsek J
    J Assist Reprod Genet; 2006 Mar; 23(3):141-7. PubMed ID: 16758344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.
    Hall JE; Taylor AE; Hayes FJ; Crowley WF
    J Endocrinol Invest; 1998 Oct; 21(9):602-11. PubMed ID: 9856414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.
    Barnes RB
    J Endocrinol Invest; 1998 Oct; 21(9):567-79. PubMed ID: 9856411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
    Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
    Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
    Welt CK; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-inhibin levels in polycystic ovary syndrome: relationship to the serum androstenedione level.
    Pigny P; Desailloud R; Cortet-Rudelli C; Duhamel A; Deroubaix-Allard D; Racadot A; Dewailly D
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1939-43. PubMed ID: 9177410
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.